Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.
作者： L Gianni , C M Kearns , A Giani , G Capri , L Viganó
DOI: 10.1200/JCO.1995.13.1.180
关键词: Metabolism 、 Paclitaxel 、 Pharmacology 、 Pharmacodynamics 、 Cancer 、 Chemotherapy 、 Medicine 、 Toxicity 、 Pharmacokinetics 、 Disposition
摘要: PURPOSE To characterize and model the disposition of paclitaxel in humans and define a pharmacodynamic relationships between paclitaxel disposition and its toxicity and efficacy. …
elsevier.com
sci-hub.se 参考文章(27)
E. Munzone, G. Capri, L. Gianni, M. Straneo, Paclitaxel (Taxol) efficacy in patients with advanced breast cancer resistant to anthracyclines Seminars in Oncology. ,vol. 21, pp. 29- 33 ,(1994)
D. C. Tormey, K. D. Tutsch, J. K. V. Willson, Santhanam Swaminathan, K. J. Simon, J. L. Grem, D. B. Alberti, D. L. Trump, Phase I study of taxol administered as a short i.v. infusion daily for 5 days. Cancer treatment reports. ,vol. 71, pp. 1179- 1184 ,(1987)
David S. Ettinger, Philip J. Burke, Robert W. Tucker, Ross C. Donehower, Eric K. Rowinsky, Judith E. Karp, Phase I and pharmacodynamic study of taxol in refractory acute leukemias. Cancer Research. ,vol. 49, pp. 4640- 4647 ,(1989)
E A Eisenhauer, W W ten Bokkel Huinink, K D Swenerton, L Gianni, J Myles, M E van der Burg, I Kerr, J B Vermorken, K Buser, N Colombo, European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. Journal of Clinical Oncology. ,vol. 12, pp. 2654- 2666 ,(1994) , 10.1200/JCO.1994.12.12.2654
A DeLean, P J Munson, D Rodbard, Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. American Journal of Physiology-endocrinology and Metabolism. ,vol. 235, ,(1978) , 10.1152/AJPENDO.1978.235.2.E97
T Walle, G N Kumar, U K Walle, Cytochrome P450 3A-mediated human liver microsomal taxol 6 alpha-hydroxylation. Journal of Pharmacology and Experimental Therapeutics. ,vol. 268, pp. 1160- 1165 ,(1994)
G Sarosy, E Kohn, D A Stone, M Rothenberg, J Jacob, D O Adamo, F P Ognibene, R E Cunnion, E Reed, Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer. Journal of Clinical Oncology. ,vol. 10, pp. 1165- 1170 ,(1992) , 10.1200/JCO.1992.10.7.1165
J.G. Wagner, Kinetics of pharmacologic response I. Proposed relationships between response and drug concentration in the intact animal and man Journal of Theoretical Biology. ,vol. 20, pp. 173- 201 ,(1968) , 10.1016/0022-5193(68)90188-4
David Z D'argenio, Alan Schumitzky, A program package for simulation and parameter estimation in pharmacokinetic systems Computer Programs in Biomedicine. ,vol. 9, pp. 115- 134 ,(1979) , 10.1016/0010-468X(79)90025-4
James W. Harris, Aspandiar Katki, Lawrence W. Anderson, Gwendolyn N. Chmurny, Joseph V. Paukstelis, Jerry M. Collins, Isolation, Structural Determination, and Biological Activity of 6.alpha.-Hydroxytaxol, the Principal Human Metabolite of Taxol Journal of Medicinal Chemistry. ,vol. 37, pp. 706- 709 ,(1994) , 10.1021/JM00031A022